Login / Signup

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy.

Hamdy N El-TallawySawsan AbuhamdahAhmed Y NassarWafaa M A FarghalyTahia H SaleemSara A AttaAyat A SayedAmal M TohamyMohammed H Hassan
Published in: Pharmacogenomics and personalized medicine (2021)
Mutation of both GPHN (rs928553) and CYP2C9 (rs1278237) genes may be implicated as a genetic mediators of resistance in patients with PRE.
Keyphrases
  • genome wide
  • bioinformatics analysis
  • gene expression
  • transcription factor
  • genome wide analysis
  • temporal lobe epilepsy